Big Gain For Sierra Oncology, Inc.
Mon, Dec 02, 2019 at 05:30 PM
Sierra Oncology, Inc. (SRRA:NASDAQ) shot up at $0.5, representing a gain of 44.2%. On Fri 29 Nov 19, SRRA:NASDAQ hit a New 2-Week High of $0.35. The stock got featured on our News Catalysts scanner on Tue 26 Nov 19 at 07:37 AM in the 'PUBLIC OFFERING' category. From Fri 08 Nov 19, the stock recorded 42.86% Up Days and 20.00% Green Days
About Sierra Oncology, Inc. (SRRA:NASDAQ)
Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.
Top 10 Gainers:
- Kodiak Sciences Inc. (KOD:NASDAQ), 72.47%
- Onconova Therapeutics, Inc. (ONTX:NASDAQ), 56.33%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 44.22%
- Yield10 Bioscience, Inc. (YTEN:NASDAQ), 41.09%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 36.13%
- Oramed Pharmaceuticals Inc. (ORMP:NASDAQ), 29.71%
- Galmed Pharmaceuticals Ltd. (GLMD:NASDAQ), 29.33%
- NF Energy Saving Corporation (BIMI:NASDAQ), 28.9%
- SAExploration Holdings, Inc. (SAEX:NASDAQ), 28.57%
- Hexindai Inc. (HX:NASDAQ), 26.88%